Glucose-6-phosphate dehydrogenase deficiency
Glucose-6-phosphate dehydrogenase deficiency
Glucose-6-phosphate dehydrogenase (G6PD) is the first enzyme of the pentose phosphate pathway, providing reducing power to all cells in the form of reduced form of nicotinamide adenine dinucleotide phosphate. G6PD deficiency is the most common human enzyme defect, being present in more than 400 million people worldwide. G6PD deficiency is an X-linked, hereditary genetic defect caused by mutations in the G6PD gene. Clinical presentations include acute hemolytic anemia, chronic hemolytic anemia, neonatal jaundice, and favism, which is usually triggered by an exogenous agent. (Turk Arch Ped 2009; 44 Suppl: 35-8)
WOS: 000266933800007
- Cukurova University Turkey
treatment, Diagnosis, glucose-6-phosphate dehydrogenase, hemolytic anemia, childhood
treatment, Diagnosis, glucose-6-phosphate dehydrogenase, hemolytic anemia, childhood
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).0 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!